Cargando…

Prevention and Management of Chronic Hepatitis B

Chronic hepatitis B virus (HBV) infection affects an estimated 370 million people worldwide. HBV is endemic throughout the world, and insidiously causes liver damage over years and decades without any warning symptoms or signs. Up to 25–35% of infected individuals eventually die due to complications...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhat, Mamatha, Ghali, Peter, Deschenes, Marc, Wong, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635410/ https://www.ncbi.nlm.nih.gov/pubmed/26622990

Ejemplares similares

Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012)

Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients
por: Bhat, Mamatha, et al.
Publicado: (2017)

Chylous Ascites: Evaluation and Management
por: Al-Busafi, Said A., et al.
Publicado: (2014)

Endoscopic Management of Portal Hypertension
por: Al-Busafi, Said A., et al.
Publicado: (2012)

Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis
por: Sebastiani, Giada, et al.
Publicado: (2015)

Unmet need in chronic hepatitis B management
por: Liang, Lilian Yan, et al.
Publicado: (2019)

Prevention and Management of Gastroesophageal Varices in Cirrhosis
por: Chen, Yen-I, et al.
Publicado: (2012)

Multi-omic Characterization of COVID Hepatitis
por: Bhat, Mamatha
Publicado: (2022)

Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome
por: Shengir, Mohamed, et al.
Publicado: (2020)

Management of Antiviral Resistance in Chronic Hepatitis B
por: Lim, Young-Suk
Publicado: (2017)

Novel biomarkers for the management of chronic hepatitis B
por: Inoue, Takako, et al.
Publicado: (2020)

Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend
por: Wong, Grace Lai-Hung
Publicado: (2018)

Recent Advances in the Management of Chronic Hepatitis B
por: Kim, Soo Ryang, et al.
Publicado: (2011)

Management of chronic hepatitis B during pregnancy
por: Aslam, Aysha, et al.
Publicado: (2018)

Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management
por: Vachon, Alicia, et al.
Publicado: (2021)

A Practical Approach to Management of Chronic Hepatitis B
por: Hu, Ke-Qin
Publicado: (2005)

New perspectives of biomarkers for the management of chronic hepatitis B
por: Lin, Chih-Lin, et al.
Publicado: (2016)

Management of Chronic Hepatitis B in HIV-Coinfected Patients
por: Fasano, Massimo, et al.
Publicado: (2022)

Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2020)

The use of transient elastography in the management of chronic hepatitis B
por: Fung, James, et al.
Publicado: (2011)

Chronic hepatitis B infection and liver cancer
por: Wong, CH, et al.
Publicado: (2006)

Non‐alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: A systematic review and meta‐analysis
por: Shengir, Mohamed, et al.
Publicado: (2021)

Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients
por: Teng, Wei, et al.
Publicado: (2021)

New approaches in the management of chronic hepatitis B: role of tenofovir
por: Reijnders, Jurriën GP, et al.
Publicado: (2009)

KASL Clinical Practice Guidelines: Management of chronic hepatitis B
Publicado: (2012)

KASL clinical practice guidelines: management of chronic hepatitis B
Publicado: (2016)

KASL clinical practice guidelines for management of chronic hepatitis B
Publicado: (2019)

The role of different viral biomarkers on the management of chronic hepatitis B
por: Mak, Lung-Yi, et al.
Publicado: (2023)

Current and novel modalities for management of chronic hepatitis B infection
por: Salama, Iman Ibrahim, et al.
Publicado: (2023)

Repurposing UDCA, an FXR Inhibitor, to Prevent SARS-Cov-2 Infection
por: Prayitno, Khairunnadiya, et al.
Publicado: (2023)

Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection
por: Benmassaoud, Amine, et al.
Publicado: (2018)

Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine
por: Colombatto, Piero, et al.
Publicado: (2022)

Chronic Viral Hepatitis in Elite Athletes: Approaches to Risk Assessment, Prevention and Management
por: Mak, Lung-Yi, et al.
Publicado: (2022)

Guidelines for Prevention and Treatment of Chronic Hepatitis B
por: Wang, Guiqiang, et al.
Publicado: (2021)

Is It Time for Treatment as Prevention of Chronic Hepatitis B?
por: Perez-Molina, Jose A., et al.
Publicado: (2023)

Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study
por: Alhinai, Alshaima, et al.
Publicado: (2021)

Chronic Hepatitis B: Management Challenges in Resource-Poor Coun-tries
por: Nwokediuko, Sylvester Chuks
Publicado: (2011)

Current role of transient elastography in the management of chronic hepatitis B patients
por: Yu, Jung Hwan, et al.
Publicado: (2017)

New Approaches to the Treatment of Chronic Hepatitis B
por: Alexopoulou, Alexandra, et al.
Publicado: (2020)

Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
por: Kim, Soo Ryang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jj69ak7h06n2oq1q14sr9lon34